Cofactor indicator compositions

• US 4,394,444 A
• Filed: 06/21/1982
• Issued: 07/19/1983
• Est. Priority Date: 06/21/1982
• Status: Expired due to Fees

• Current Assignee: Miles Laboratories, Inc. (Bayer AG)
• Original Assignee: Miles Laboratories, Inc. (Bayer AG)
• Inventors: White-Stevens, Rodric H., Gunter, Claude R., Cameron, Erma C.
• Primary Examiner(s): Hruskoci, Peter A.
• Application Number:
  US06/390,252
• Time in Patent Office: 393 Days
• Field of Search: 252/408 R, 424/2, 424/7, 435/4, 435/11, 435/14, 435/18, 435/20, 435/25, 435/26, 435/28, 435/805, 435/810, 435/15, 436/34, 436/904
• US Class Current: 435/11
• CPC Class Codes: C12Q 1/008 for determining co-enzymes or co-factors, e.g. NAD, ATP
• CPC Class Codes: C12Q 1/26 involving oxidoreductase
• CPC Class Codes: C12Q 1/54 involving glucose or galactose
• CPC Class Codes: C12Q 1/60 involving cholesterol
• CPC Class Codes: Y10S 435/805 Test papers
• CPC Class Codes: Y10S 435/81 Packaged device or kit

Abstract

A composition, test device, method of making a test device and process for determination of an analyte in a liquid sample are disclosed. More particularly, there is provided a composition for the determination of an analyte in a sample which composition comprises an analyte-responsive component comprising a pyridine nucleotide susceptible of reduction in response to the presence of said analyte and at least one constituent interreactive with said analyte to cause reduction of the pyridine nucleotide, an uncoupler effective to generate an oxidizing substance from the reduced form of said pyridine nucleotide, a peroxidatively active substance, and an indicator which, when oxidized, is not susceptible to reduction by said reduced pyridine nucleotide. The pyridine nucleotide can be nicotine adenine dinucleotide (NAD) or nicotine adenine dinucleotide phosphate (NADP).

Claims

1. A composition for the determination of an analyte in a sample which composition comprises:

an analyte-responsive component comprising a pyridine nucleotide susceptible of reduction in response to the presence of said analyte and at least one constituent interreactive with said analyte to cause reduction of the pyridine nucleotide;

a hydroxylase capable of being uncoupled and a pseudosubstrate capable of uncoupling said hydroxylase, which hydroxylase and pseudosubstrate, in the presence of the reduced form of said pyridine nucleotide, are effective to generate hydrogen peroxide;

a peroxidatively active substance; and

a hydrazone indicator comprising a hydrazone and a coupler, which indicator, when in its oxidized form, cannot be reduced by said pyridine nucleotide.

2. The composition of claim 1 wherein said pyridine nucleotide is nicotine adenine dinucleotide.

3. The composition of claim 1 wherein said pyridine nucleotide is nicotine adenine dinucleotide phosphate.

4. The composition of claim 1 wherein said at least one interreactive constitutent is an analyte-specific enzyme.

5. The composition of claim 4 wherein said enzyme is a dehydrogenase.

6. The composition of claim 5 wherein said enzyme is lactate dehydrogenase.

7. The composition of claim 5 wherein said enzyme is β

-hydroxybutyrate dehydrogenase.

8. The composition of claim 5 wherein said enzyme is α

-hydroxybutyrate dehydrogenase.

9. The composition of claim 5 wherein said enzyme is alcohol dehydrogenase.

10. The composition of claim 5 wherein said enzyme is a steroid dehydrogenase.

11. The composition of claim 10 wherein said enzyme is cholesterol dehydrogenase.

12. The composition of claim 5 wherein said enzyme is glucose dehydrogenase.

13. The composition of claim 1 wherein said at least one interreactive constituent is an analyte-specific enzyme and an enzyme interreactive with the product of the reaction of said analyte-specific enzyme with the analyte.

14. The composition of claim 13 wherein said analyte-responsive enzyme is a lipase and said enzyme interreactive with the product of the reaction of said lipase with the analyte is glycerol dehydrogenase.

15. The composition of claim 13 wherein said analyte-specific enzyme is hexokinase and said enzyme interreactive with the product of the reaction of said hexokinase with the analyte is glucose-6-phosphate dehydrogenase.

16. The composition of claim 1 wherein said interreactive component is a substrate of the analyte.

17. The composition of claim 16 wherein said interreactive component is a reduced substrate.

18. The composition of claim 17 wherein said interreactive component is lactate.

19. The composition of claim 17 wherein said interreactive component is β

-hydroxybutyric acid.

20. The composition of claim 17 wherein said interreactive component is α

-hydroxybutyric acid.

21. The composition of claim 17 wherein said interreactive component is ethanol.

22. The composition of claim 17 wherein said interreactive component is a steroid.

23. The composition of claim 22 wherein said interreactive component is cholesterol.

24. The composition of claim 17 wherein said interreactive component is glucose.

25. The composition of claim 1 wherein said at least one interreactive constituent is an analyte-specific substrate and an enzyme interreactive with the product of the reaction of said analyte-specific substrate with the analyte.

26. The composition of claim 25 wherein said analyte-specific substrate is a triglyceride and said enzyme interreactive with the product of the reaction of said triglyceride with the analyte is glycerol dehydrogenase.

27. The composition of claim 25 wherein said analyte-specific substrate is glucose and said enzyme interreactive with the product of the reaction of said glucose with the analyte is glucose-6-phosphate dehydrogenase.

28. The composition of claim 1 wherein said hydroxylase capable of being uncoupled is salicylate hydroxylase and said pseudosubstrate is a benzoate.

29. The composition of claim 1 wherein said hydroxylase capable of being uncoupled is p-hydroxybenzoate hydroxylase and said pseudosubstrate is 6-hydroxynicotinate.

30. The composition of claim 1 wherein said peroxidatively active substance is a peroxidase.

31. The composition of claim 1 wherein said hydrazone is 3-methyl-2-benzothiazolinone hydrazone.

32. The composition of claim 31 wherein said coupler is primaquine.

33. A device for the determination of an analyte in a sample which comprises a carrier incorporated with the composition of claim 1.

34. A method for the determination of an analyte in a sample which comprises contacting said sample with the device of claim 33 and observing any resultant color change thereon.

35. A process for preparing a device for the determination of an analyte in a sample which comprises incorporating a carrier with the composition of claim 1.

36. A method for the determination of an analyte in a sample which comprises contacting said sample with the composition of claim 1 and observing any resultant color change.